Acreage (OTCMKTS:ACRGF – Get Free Report) and Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.
Institutional and Insider Ownership
83.4% of Lifecore Biomedical shares are held by institutional investors. 32.7% of Lifecore Biomedical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a summary of current recommendations and price targets for Acreage and Lifecore Biomedical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Acreage | 0 | 0 | 0 | 0 | 0.00 |
| Lifecore Biomedical | 1 | 2 | 1 | 0 | 2.00 |
Earnings and Valuation
This table compares Acreage and Lifecore Biomedical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Acreage | N/A | N/A | N/A | N/A | N/A |
| Lifecore Biomedical | $128.87 million | 1.33 | -$40.50 million | ($1.07) | -4.24 |
Acreage has higher earnings, but lower revenue than Lifecore Biomedical.
Profitability
This table compares Acreage and Lifecore Biomedical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Acreage | N/A | N/A | N/A |
| Lifecore Biomedical | -29.93% | N/A | -16.16% |
Summary
Lifecore Biomedical beats Acreage on 6 of the 8 factors compared between the two stocks.
About Acreage
Acreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.
About Lifecore Biomedical
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Receive News & Ratings for Acreage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acreage and related companies with MarketBeat.com's FREE daily email newsletter.
